EBS names new CFO as Lindahl retires
- Richard Lindahl to step down as CFO Dec 31, 2026
- Frank Vargo to become interim CFO Jan 1, 2027
- Vargo gets $3,850 extra per pay period
EBS
Emergent BioSolutions Inc. SEC filings
Every EDGAR filing for Emergent BioSolutions Inc. (EBS), newest first, with AI summaries and stories.
- Ticker
- EBS
- CIK
- 1367644
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 9 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 2 open-market sales ($146K).
Filings
8-KEmergent BioSolutions Inc.EBSLIVE 4Emergent BioSolutions Inc.EBSLIVE DeGolyer Donald W sold shares of EBS
- Sold 17,800 shares on 10/07/2026
- Price range $6.88 to $7.24
- Sold under Rule 10b5-1 trading plan
Donald W DeGolyer, reporting
144Emergent BioSolutions Inc.EBSLIVE DeGolyer Donald sells EBS shares
- 17,800 shares to be sold
- Aggregate market value $126,120.12
- Date of sale: 10/07/2026
Donald W DeGolyer, reporting
4Emergent BioSolutions Inc.EBSLIVE EBS: Williams sold 3,000 shares
- Sold 3,000 shares on 10/01/2026
- Price range $6.52-$6.56
- Reported by SVP, Products Business
Paul Anthony Williams
144Emergent BioSolutions Inc.EBSLIVE Paul Anthony Williams, planned sale of EBS shares
Paul Anthony Williams
8-KEmergent BioSolutions Inc.EBSLIVE 8-KEmergent BioSolutions Inc.EBSLIVE SCHEDULE 13GEmergent BioSolutions Inc.EBSLIVE Ownership stake disclosure by AMERICAN CENTURY INVESTMENT MANAGEMENT INC
AMERICAN CENTURY INVESTMENT MANAGEMENT INC, filed by
3Emergent BioSolutions Inc.EBSLIVE Stephanie Duatschek, new insider at EBS
Stephanie Duatschek, reporting
8-KEmergent BioSolutions Inc.EBSLIVE SCHEDULE 13G/AEmergent BioSolutions Inc.EBSLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC (amended)
VANGUARD CAPITAL MANAGEMENT LLC, filed by
SCHEDULE 13G/AEmergent BioSolutions Inc.EBSLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
4Emergent BioSolutions Inc.EBSLIVE Paul Anthony Williams, insider filing for EBS
Paul Anthony Williams, reporting
144Emergent BioSolutions Inc.EBSLIVE Paul Anthony Williams, planned sale of EBS shares
Paul Anthony Williams, reporting
8-KEmergent BioSolutions Inc.EBSLIVE 4Emergent BioSolutions Inc.EBSLIVE 4 insider filings
Paul Anthony Williams, insider filing for EBS
Show all 4
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
Paul Anthony Williams, reporting
4Emergent BioSolutions Inc.EBSLIVE 9 insider filings
Sujata Tyagi Dayal, insider filing for EBS
Show all 9
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
Sujata Tyagi Dayal, reporting
4Emergent BioSolutions Inc.EBSLIVE 7 insider filings
Paul Anthony Williams, insider filing for EBS
Show all 7
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
- 4Insider filing for EBS
Paul Anthony Williams, reporting
144Emergent BioSolutions Inc.EBSLIVE 3 Form 144 notices
Sujata Tyagi Dayal, planned sale of EBS shares
Show all 3
- 144Planned insider sale of EBS shares
- 144Planned insider sale of EBS shares
- 144Planned insider sale of EBS shares
Sujata Tyagi Dayal, reporting
S-8Emergent BioSolutions Inc.EBSLIVE 8-KEmergent BioSolutions Inc.EBSLIVE 144Emergent BioSolutions Inc.EBSLIVE Keith Katkin, planned sale of EBS shares
Keith Katkin, reporting
8-KEmergent BioSolutions Inc.EBSLIVE SCHEDULE 13GEmergent BioSolutions Inc.EBSLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
DEFA14AEmergent BioSolutions Inc.EBSLIVE DEFA14AEmergent BioSolutions Inc.EBSLIVE DEFA14AEmergent BioSolutions Inc.EBSLIVE DEFA14AEmergent BioSolutions Inc.EBSLIVE DEFA14AEmergent BioSolutions Inc.EBSLIVE SCHEDULE 13GEmergent BioSolutions Inc.EBSLIVE Ownership stake disclosure by DIMENSIONAL FUND ADVISORS LP
DIMENSIONAL FUND ADVISORS LP, filed by
4Emergent BioSolutions Inc.EBSLIVE Paul Anthony Williams, insider filing for EBS
Paul Anthony Williams, reporting